MetLife Investment Management’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-18,962
| Closed | -$73.2K | – | 2866 |
|
|
2025
Q1 | $73.2K | Sell |
18,962
-372
| -2% | -$1.44K | ﹤0.01% | 2633 |
|
|
2024
Q4 | $119K | Hold |
19,334
| – | – | ﹤0.01% | 2538 |
|
|
2024
Q3 | $104K | Buy |
+19,334
| New | +$104K | ﹤0.01% | 2611 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 2893 |
|
|
2023
Q3 | – | Sell |
-22,045
| Closed | -$139K | – | 2914 |
|
|
2023
Q2 | $139K | Hold |
22,045
| – | – | ﹤0.01% | 2493 |
|
|
2023
Q1 | $127K | Hold |
22,045
| – | – | ﹤0.01% | 2454 |
|
|
2022
Q4 | $226K | Hold |
22,045
| – | – | ﹤0.01% | 2177 |
|
|
2022
Q3 | $369K | Buy |
22,045
+5,160
| +31% | +$86.3K | ﹤0.01% | 1857 |
|
|
2022
Q2 | $236K | Hold |
16,885
| – | – | ﹤0.01% | 2197 |
|
|
2022
Q1 | $273K | Buy |
16,885
+6,021
| +55% | +$97.2K | ﹤0.01% | 2153 |
|
|
2021
Q4 | $233K | Buy |
+10,864
| New | +$233K | ﹤0.01% | 1962 |
|